Evidence brief · printable

Type 1 Diabetes Mellitus evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Type 1 Diabetes Mellitus

Print or save as PDF Fits on one A4 or Letter page.

Type 1 Diabetes Mellitus: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 2,071 matching trials) · https://research.opensourcemed.info/briefs/type-1-diabetes.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Insulin Lispro 3 trials
  • LY900014 2 trials
  • Acetazolamide 1 trial
  • Acetylated and Butyrylated High Amylose Maize Starch 1 trial
  • Allogeneic CD7-Targeted CAR-T Cell Injection 1 trial
  • Alpha 1-Antitrypsin (AAT, Aralast NP) 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Wearables and monitoring devices 65 trials · 31 completed · 21 with results
  • Education, coaching and self-management 95 trials · 48 completed · 14 with results
  • Dietary patterns and specific diets 28 trials · 13 completed · 7 with results
  • Vitamin D 11 trials · 9 completed · 6 with results
  • Aerobic and endurance exercise 16 trials · 8 completed · 2 with results
  • Psychotherapy, counselling and peer support 17 trials · 6 completed · 2 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Vitamin D3
  • Omega-3 Fatty Acids
  • Magnesium
  • Vitamin C
  • Zinc
  • Saffron

Biomarkers reported

Direction in patients compared with the stated comparison group, as reported in the cited study.

  • C-Peptide lower · Yu et al. 2019
  • Fasting Plasma Glucose higher · Yang et al. 2024
  • GAD65 autoantibodies higher · Luo et al. 2004
  • HbA1c higher · Pasi et al. 2022
  • IA-2 autoantibodies higher · Mendis et al. 2023
  • ZnT8 autoantibodies higher · Bhola et al. 2021

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • INfluenza VaccInation To Mitigate typE 1 Diabetes NCT05585983
  • Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and… NCT07891156
  • A Study of GNTI-122 in Adults Recently Diagnosed With T1D NCT06919354
  • Finding Immune Nascent Type 1 Diabetes NCT07663136
  • Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1… NCT07097805
  • Intensive Dietary and Activity Counselling (IDAC) NCT06670625

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Mind-body and psychological approaches: mood, anxiety and wellbeing 16 trials, no results posted yet
  • Cognitive training and education: feasibility, adherence and safety 15 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (480 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page · biomarker atlas. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.